GB0718824D0 - Methods of treating lysosomal storage disorders - Google Patents

Methods of treating lysosomal storage disorders

Info

Publication number
GB0718824D0
GB0718824D0 GBGB0718824.6A GB0718824A GB0718824D0 GB 0718824 D0 GB0718824 D0 GB 0718824D0 GB 0718824 A GB0718824 A GB 0718824A GB 0718824 D0 GB0718824 D0 GB 0718824D0
Authority
GB
United Kingdom
Prior art keywords
methods
lysosomal storage
storage disorders
treating lysosomal
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0718824.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Priority to GBGB0718824.6A priority Critical patent/GB0718824D0/en
Publication of GB0718824D0 publication Critical patent/GB0718824D0/en
Priority to PCT/IL2008/001291 priority patent/WO2009040816A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
GBGB0718824.6A 2007-09-26 2007-09-26 Methods of treating lysosomal storage disorders Ceased GB0718824D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0718824.6A GB0718824D0 (en) 2007-09-26 2007-09-26 Methods of treating lysosomal storage disorders
PCT/IL2008/001291 WO2009040816A1 (en) 2007-09-26 2008-09-24 Methods of treating lysosomal storage disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0718824.6A GB0718824D0 (en) 2007-09-26 2007-09-26 Methods of treating lysosomal storage disorders

Publications (1)

Publication Number Publication Date
GB0718824D0 true GB0718824D0 (en) 2007-11-07

Family

ID=38701719

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0718824.6A Ceased GB0718824D0 (en) 2007-09-26 2007-09-26 Methods of treating lysosomal storage disorders

Country Status (2)

Country Link
GB (1) GB0718824D0 (en)
WO (1) WO2009040816A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2882284B1 (en) 2012-08-07 2017-11-15 Chiesi Farmaceutici S.p.A. Animal model of krabbe's disease
CA2967066A1 (en) * 2014-11-19 2016-05-26 Rush University Medical Center Use of cinnamic acid or sodium benzoate for treating lysosomal disorders
WO2019156252A1 (en) * 2018-02-06 2019-08-15 国立大学法人京都大学 Preventive and therapeutic agent for lysosomal diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321228D0 (en) * 2003-09-10 2003-10-08 Inpharmatica Ltd Modulating cell activity
EP2051583A4 (en) * 2006-08-16 2011-09-14 Aspreva Pharmaceuticals Ltd Compositions and methods for treating vascular, autoimmune, and inflammatory diseases

Also Published As

Publication number Publication date
WO2009040816A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
HRP20190521T1 (en) Novel compositions for preventing and/or treating lysosomal storage disorders
EP2155197A4 (en) Treatment of lysosomal storage diseases
HK1156631A1 (en) Novel compounds and methods for therapy
IL209032A0 (en) Compositions and methods for treating digestive disorders
EP2170309A4 (en) Methods and compositions for treating disorders
GB2466912B (en) Compositions and methods for treating lysosomal disorders
EP2300011A4 (en) Therapeutic methods and compounds
IL215583A0 (en) Methods for preventing and/or treating lysosomal storage disorders
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
IL207127A0 (en) Aldh-2 inhibitors in the treatment of addiction
GB0718824D0 (en) Methods of treating lysosomal storage disorders
EP2164494A4 (en) Methods of treatment
IL207906A0 (en) Treatment for ocular-related disorders
GB0817446D0 (en) Treatment of lysosomal storage disorders
GB0819523D0 (en) Treatment of lysosomal storage disorders
GB0814322D0 (en) Treatment of lysosomal storage disorders
GB0906175D0 (en) Treatment of lysosomal storage disorders
GB0908661D0 (en) Treatment of lysosomal storage disorders
GB0700969D0 (en) Methods of treatment
GB0809319D0 (en) The treatment of puritus
IL208831A0 (en) Methods of treating ophthalmic disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)